FDA Device Intelligence
Home › SPATZ FGIA (ISRAEL) LTD › Spatz3 Adjustable Balloon System insertion kit

Spatz3 Adjustable Balloon System insertion kit

SPATZ FGIA (ISRAEL) LTD · Model A-SP3US-03K · UDI-DI 00860005178803

LTI Prescription
0
510(k) clearances
17,689
Adverse events (191 deaths)
26
Recalls
10
Facilities

Description

The Spatz3 Adjustable Balloon System is indicated for temporary use for weight loss in adults with obesity Body Mass Index (BMI) of 35.0-40.0 kg/m2 or a BMI of 30.0 to 34.9 kg/m2 with one or more major obesity-related comorbid conditions who have failed to achieve and maintain weight-loss with a supervised weight control program. The Spatz3 Adjustable Balloon System is to be used in conjunction with a long-term supervised diet and behavior modification program designed to increase the possibility of long-term weight-loss maintenance. The maximum placement period for Spatz3 Adjustable Balloon System is 8 months.

Recalls

DateFirmReason
2019-05-23Obalon Therapeutics IncDuring initial set-up and/or replacement of the dispenser batteries, the touch dispenser touchscreen can inadvertently lose calibration. This issue can also occur if the touchscree
2017-11-22Apollo Endosurgery IncComponent of the Lap-Band system was missing from the package
2016-10-14Reshape Medical IncReShape Medical is recalling the Integrated Dual Balloon System Gen 1 due to the potential leak of distillation fluid during balloon inflation.
2016-05-04Reshape Medical IncDue to a suspected misalignment of the connection between the proximal balloon cap of the implant and the delivery catheter. The possible misalignment is the result of an assembly
2014-08-15Apollo Endosurgery IncProduct was distributed past its expiration date.
2013-09-30Ethicon Endo-Surgery IncDuring aging studies, the firm determined that the gastric belts were unable to pass the test requirements established for Force to Lock.
2013-09-30Ethicon Endo-Surgery IncDuring aging studies, the firm determined that the gastric belts were unable to pass the test requirements established for Force to Lock.
2013-09-30Ethicon Endo-Surgery IncDuring aging studies, the firm determined that the gastric belts were unable to pass the test requirements established for Force to Lock.
2011-03-21AllerganThe recall was initiated because Allergan has determined that a number of Access Port Needle pouches from one specific lot number may have small gaps in a pouch seal. Consequently
2010-09-27Ethicon Endo-Surgery IncThe Tubing Strain Relief component of the Injection Port may detach from the Locking Connector, and migrate from its original position on the Locking Connector. This may result in:

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.